Sitryx Therapeutics
高管
查看带有其 17 名主要高管的组织结构图
Sitryx Therapeutics 搜索最多的简介
高管在Sitryx Therapeutics变化
- Iain Kilty 曾任 Chief Scientific Officer, 现升职为 Chief Executive Officer (新闻发布的2024七月3号).
- Ben Stephens已作为Chief Operating Officer加入公司 (新闻发布的2024三月6号).
创建提醒
跟踪 Sitryx Therapeutics 的高管变动
生物技术
Sitryx Therapeutics 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
Sitryx Therapeutics 的最新新闻稿
- Sitryx announces leadership transition - Sitryx
- Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atopic dermatitis - Sitryx
- Sitryx Therapeutics makes key appointments to strengthen business operations and progress immunometabolism-targeting pipeline into clinical development - Sitryx
- Sitryx announces collaboration partner Lilly has commenced a Phase 1 study of SIT-011 for chronic autoimmune and inflammatory diseases - Sitryx
- Sitryx announces partner Lilly exercises option to SIT-011 for chronic autoimmune and inflammatory diseases - Sitryx
- Sitryx raises additional $39 million to progress development of disease-modifying therapeutics for chronic autoimmune and inflammatory diseases - Sitryx
- Sitryx appoints Carrie Cook as Chief Business Officer - Sitryx
- Sitryx CEO, Neil Weir, presents at BioEquity Europe 2023 - Sitryx
- Sitryx stren - Sitryx
- View more press releases Close
通过电子邮件
